- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Glycopyrronium, Indacaterol and Mometasone is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- R03AL Asthma and COPD medicines, subgroup R03A, subgroup R03AL · Asthma and COPD medicines, subgroup R03A
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Fixed-dose combination of
- Glycopyrronium, Indacaterol, Mometasone
All presentations
No presentations of Glycopyrronium, Indacaterol and Mometasone are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Glycopyrronium, Indacaterol and Mometasone available for export from India?
No presentation of Glycopyrronium, Indacaterol and Mometasone is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Glycopyrronium, Indacaterol and Mometasone authorised in the European Union?
Yes. Glycopyrronium, Indacaterol and Mometasone has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Glycopyrronium, Indacaterol and Mometasone need cold chain shipping?
No listed presentation of Glycopyrronium, Indacaterol and Mometasone is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Glycopyrronium, Indacaterol and Mometasone in?
Glycopyrronium, Indacaterol and Mometasone is classified under ATC code R03AL (Asthma and COPD medicines, subgroup R03A, subgroup R03AL).
References
- Enerzair Breezhaler: European public assessment report (EPAR). European Medicines Agency. Retrieved 20 November 2025
Request Glycopyrronium, Indacaterol and Mometasone for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.